A day after it publicly announced its new CEO, Entellus Medical Inc. has launched a new sinus-dilation tool. The company’s Xpress device uses a balloon catheter to dilate both the frontal and sphenoid sinus spaces during surgery for chronic sinusitis. The sphenoid sinuses are small cavities located deep within the skull. The device features a […]
Entellus Medical Inc., which is developing a less-invasive therapy to treat chronic sinusitis, has hired a new chief executive. Brian Farley, who has served on the company’s board since 2008 and previously led VNUS Medical Technologies Inc., takes over the CEO job from Entellus co-founder Tom Ressemann, according to a company statement. Ressemann will stay […]
A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.
The development is an important milestone for the company as it endeavors to convince more insurers to cover its FinESS sinus treatment in an office setting.